Crescentis Capital promoter transfers 1.76% stake via gift

Crescentis Capital Limited disclosed an inter-se transfer of shares within its promoter group, involving a gift of 1.76% of the company's equity share capital. Dr. Bhaskara Rao Bollineni transferred 3,00,000 equity shares to Mr. Bhavanam Ruthvik Reddy on June 24, 2026, via an off-market transaction. The transfer was executed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.

The transaction represents a redistribution of shareholding within the promoter group and does not alter the aggregate holding of the promoters. Consequently, the total promoter and promoter group shareholding remains unchanged. The disclosures regarding the transfer were submitted to BSE Limited on June 26, 2026.

Shareholding Details

The transfer modified the individual stakes of the two promoters. Dr. Bhaskara Rao Bollineni's holding decreased from 68.80% to 67.04%, while Mr. Bhavanam Ruthvik Reddy's stake increased from 6.17% to 7.94%.

Promoter	Holding Before (%)	Holding After (%)	Change (%)
Dr. Bhaskara Rao Bollineni	68.80%	67.04%	- 1.76%
Mr. Bhavanam Ruthvik Reddy	6.17%	7.94%	+ 1.76%

Transaction Breakdown

The specific details of the inter-se transfer are outlined below:

Transferor (Donor)	Transferee (Donee)	No. of Shares	% of Total Share/ Voting Capital	Date of Transfer
Dr. Bhaskara Rao Bollineni	Mr. Bhavanam Ruthvik Reddy	3,00,000	1.76%	24th June, 2026

The equity share capital of the company remains at 1,70,13,549 equity shares of ₹10 each before and after the transaction.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-1.17%	-7.55%	-6.45%	-7.74%	-5.82%	+248.62%

Crescentis Capital Limited reported a net loss of ₹252.63 lakh for the financial year ended March 31, 2026, narrowing from a loss of ₹542.24 lakh in the previous year. The board approved the audited financial results for the quarter and year ended March 31, 2026, at a meeting held on May 29, 2026. Additionally, the board approved a proposal to raise funds up to ₹80 crore through a rights issue of fully paid-up equity shares. The company confirmed that its statutory auditors, M/s. D.S. Talwar & Co., Chartered Accountants, have issued an audit report with an unmodified opinion for the financial year ended March 31, 2026.

Financial Performance

The company reported total revenue from operations of ₹148.38 lakh for FY26, compared to negative revenue of ₹302.48 lakh in FY25. Total income for the year stood at ₹154.60 lakh. Total expenses increased to ₹474.97 lakh from ₹279.68 lakh in the previous year. The basic and diluted earnings per share (EPS) for FY26 was a loss of ₹1.57, improving from a loss of ₹4.48 in FY25.

Metric	FY26 (₹ lakh)	FY25 (₹ lakh)
Net Profit/Loss	(252.63)	(542.24)
Total Revenue from Operations	148.38	(302.48)
Total Income	154.60	(302.21)
Total Expenses	474.97	279.68
Basic EPS	(1.57)	(4.48)

Rights Issue Proposal

Pursuant to Regulation 30 read with Schedule III of the SEBI (LODR) Regulations and Chapter III of the SEBI ICDR Regulations, the board considered a proposal for raising funds up to an aggregate amount of ₹80 crore. The funds will be raised by way of issue of fully paid-up equity shares of ₹10 each to eligible equity shareholders on a rights basis. The record date for the rights issue will be announced later. The board constituted a Fund Raising Committee to finalize the terms, including the rights entitlement ratio and issue price.

Operational Highlights

For the year ended March 31, 2026, the company recognized an unrealized loss of ₹485.47 lakh due to adverse movements in market prices of its equity investments. The company successfully concluded a previous rights issue in July 2025, raising ₹4,903.91 lakh through the issuance of 70,05,579 equity shares at ₹70 per share. The proceeds were fully utilized during the year for the stated objects. The company also introduced the Crescentis Capital Limited Employees Stock Option Scheme, 2025, approved by shareholders in December 2025.